Japan Approves Muscular Dystrophy Drug Price of 300 M. Yen
Tokyo, Feb. 13 (Jiji Press)–An advisory panel to Japan’s health minister decided Friday to allow public health insurance coverage for a gene therapy for muscular dystrophy beginning Feb. 20 and set the drug’s official price at about 304.97 million yen. Elevidys, a